Your selections:
Biomarkers of platinum resistance in ovarian cancer: What can we use to improve treatment
- Van Zyl, Belinda, Tang, Denise, Bowden, Nikola A.
- Sun, Xiao-Jin, Zhang, Pei, Li, Hai-Hui, Jiang, Zhi-Wen, Jiang, Chen-Chen, Liu, Hao
- Bowden, N. A., Ashton, K. A., Avery-Kiejda, K. A., Zhang, X. D., Hersey, P., Scott, R. J.
- Goldstein, David, Gainford, M Corona, Miller, Danielle, Shannon, Jenny, Brown, Chris, Tebbutt, Niall, Ackland, Stephen P., van Hazel, Guy, Jefford, Michael, Abdi, Ehtesham, Selva-Nayagam, Sid, Gebski, Val
- Zhang, Xu Dong, Wu, Jing Jing, Gillespie, Susan, Borrow, Jodie, Hersey, Peter
Inhibition of apoptosis facilitates necrosis induced by cisplatin in gastric cancer cells
- Zhang, Lin Jie, Hao, Yuan Zhang, Hu, Chun Song, Ye, Yan, Xie, Qi Peng, Thorne, Rick F., Hersey, Peter, Zhang, Xu Dong
Nucleotide excision repair gene expression after cisplatin treatment in melanoma
- Bowden, Nikola A., Ashton, Katie A., Kiejda, Kelly A., Zhang, Xu Dong, Hersey, Peter, Scott, Rodney J.
Nucleotide excision repair: why is it not used to predict response to platinum-based chemotherapy?
- Rischin, D., Mehanna, H., Porceddu, S., Wratten, C., Robinson, M., Solomon, B. J., Young, R. J., Bressel, M., Dunn, J., Corry, J., Soni, P., Fulton-Lieuw, T., Iqbal, G., Kenny, L.
Are you sure you would like to clear your session, including search history and login status?